Abdulkareem Sultan Al Olama – CEO, Al Jalila Foundation, UAE
Dr Abdulkareem Sultan Al Olama, CEO of the Al Jalila Foundation, discusses the Foundation’s goal to position the UAE at the forefront of medical education and research, the importance of…
Al Jalila Foundation, a global philanthropic organisation dedicated to transforming lives through medical research, education and treatment was founded by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the United Arab Emirates (UAE) and Ruler of Dubai in April 2013, to position Dubai and the UAE at the forefront of medical innovation.
Al Jalila Foundation promotes medical education and research by investing in the UAE’s medical treatment capabilities; it provides scholarships to nurture a home-grown generation of medical professionals and supports ground-breaking research that addresses health challenges prevalent in the region. Al Jalila Foundation Research Centre, located in Dubai Healthcare City, is a beacon for regionally-relevant medical innovation produced by home-grown biomedical researchers. The UAE’s first independent multi-disciplinary medical research centre focuses on five of the most pressing regional health challenges: cancer, cardiovascular diseases, diabetes, obesity and mental health. Benefitting from the Foundation’s global outreach, Al Jalila Foundation Research Centre brings together international best practice and regional expertise in a cultivating environment with state-of-the-art facilities.
Contact
Al Jalila Foundation, First Floor, Building 12, Dubai Healthcare City
P.O. Box 300100, Dubai, United Arab Emirates
Tel: +971 4 383 8000
Dr Abdulkareem Sultan Al Olama, CEO of the Al Jalila Foundation, discusses the Foundation’s goal to position the UAE at the forefront of medical education and research, the importance of…
Long-established as the Middle East and Africa’s leading country in terms of rapid access to biomedical innovation, the UAE is looking to bolster this positioning in the coming years. Indeed,…
Roula Youssef Halabi, SVP Global Fertility Services, discusses her six-year journey at CooperSurgical, establishing a footprint in the Middle East, overcoming cultural biases as a female executive and the shift…
Rami Rajab, CEO of the medical devices trade association, MECOMED, walks us through the organization’s current priorities, including its focus on Saudi Arabia in light of the kingdom’s ongoing transformation,…
Karim Smaira and Kamel Ghammachi, founders of Genpharm, underscores the strategic significance of the recent majority acquisition by Abdul Latif Jameel Health, part of Abdul Latif Jameel, driven by a…
Sovereign wealth funds (SWFs) in the Gulf Cooperation Council (GCC) countries are increasingly investing in healthcare and the life sciences to reinforce their local industries and pursue the region’s economic…
Maher Abouzeid outlines Medserve’s role as a healthcare projects incubator, focusing on identifying and filling gaps in healthcare services across the Middle East & Africa region. Their hands-on approach includes…
Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors…
A charismatic force at the forefront of the country’s health transformation efforts, Dr Amin Al Amiri currently serves as assistant undersecretary at the UAE Ministry of Health as well as…
Drawing on a quarter of a century of pharmaceutical industry experience, over 20 years of which has been spent in the UAE, Ayman Mokhtar today heads up Middle East, North…
Globally, while there is broad stakeholder alignment on topics like clinical trials and innovation, there is real divergence in approaches to pharmacoeconomics and health technology assessment (HTA). This is perhaps…
From humble origins, taiba can now count on a unique two decades of experience in bringing innovative rare disease products to patients across the MENA region. The Dubai headquartered company,…
Thanks to favourable regulations from the Ministry of Health and Prevention (MoHaP) which include fast-track regulatory pathways, patients in the UAE are gaining access to innovative medicines in similar time…
See our Cookie Privacy Policy Here
